In this webinar, our guest speakers will be discussing how to harness the full power of this disease-agnostic RNA platform, the key considerations needed for consistent, high-quality mRNA synthesis and how you can intensify manufacturing for rapid therapeutic production.

Here, Dr. Riglar will discuss ways that we are using synthetic biology to solve this problem, and our quest to develop non-invasive living engineered bacterial tools – smart probiotics – to help us understand and control the gut and gut microbiota.

Co-targeting of two receptors or ligands that are involved in modulating a patient’s immune system via a single molecular format provides advantages over the co-administration of two biologics.

Co-targeting of two receptors or ligands that are involved in modulating a patient’s immune system via a single molecular format provides advantages over the co-administration of two biologics.

In this webinar, our expert speaker Dr. Ceri Fielding, from the division of infection and immunity at Cardiff University, will discuss the need to understand how viruses interact with NK cells during the development of novel antiviral therapies.

Design–build–test–learn (DBTL) cycles are commonly used in biotechnology and in natural product discovery as they provide a systemic and efficient framework for the metabolic engineering of microbes.

A novel platform that automates multiomics analyses of microbes could enable faster and better DBLT cycles for your research. In this webinar, the development and validation of the high-throughput, automated platform using model microbial organisms is described, as well as the recent work in applying the platform to cell factory and natural products engineering.